<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ropponen HK</submitter><funding>Helmholtz Association</funding><funding>Verband der Chemischen Industrie</funding><pagination>593-601</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8128065</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(4)</volume><pubmed_abstract>In the search for new antibacterial compounds, we repositioned an antimalarial compound class by derivatising it based on the so-called "eNTRy" rules for enhanced accumulation into Gram-negative bacteria. We designed, synthesised and evaluated a small library of amino acid modified compounds together with the respective Boc-protected analogues, leading to no substantial improvement in antibacterial activity against &lt;i>Escherichia coli&lt;/i> wild-type K12, whereas more distinct activity differences were observed in &lt;i>E. coli&lt;/i> mutant strains Δ&lt;i>tolC&lt;/i>, D22, Δ&lt;i>acrB&lt;/i> and BL21(DE3)omp8. A comparison of the activity results of the &lt;i>E. coli&lt;/i> mutants with respect to the known rules related to enhanced activity against Gram-negative bacteria revealed that applicability of the rules i</pubmed_abstract><journal>RSC medicinal chemistry</journal><pubmed_title>Assessment of the rules related to gaining activity against Gram-negative bacteria.</pubmed_title><pmcid>PMC8128065</pmcid><funding_grant_id>Kekulé Mobility Fellowship</funding_grant_id><funding_grant_id>Initiative and Networking Fund</funding_grant_id><pubmed_authors>Hirsch AKH</pubmed_authors><pubmed_authors>Ropponen HK</pubmed_authors><pubmed_authors>Rottmann M</pubmed_authors><pubmed_authors>Fischer M</pubmed_authors><pubmed_authors>Illarionov B</pubmed_authors><pubmed_authors>Haupenthal J</pubmed_authors><pubmed_authors>Siemens A</pubmed_authors><pubmed_authors>Witschel M</pubmed_authors><pubmed_authors>Diamanti E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assessment of the rules related to gaining activity against Gram-negative bacteria.</name><description>In the search for new antibacterial compounds, we repositioned an antimalarial compound class by derivatising it based on the so-called "eNTRy" rules for enhanced accumulation into Gram-negative bacteria. We designed, synthesised and evaluated a small library of amino acid modified compounds together with the respective Boc-protected analogues, leading to no substantial improvement in antibacterial activity against &lt;i>Escherichia coli&lt;/i> wild-type K12, whereas more distinct activity differences were observed in &lt;i>E. coli&lt;/i> mutant strains Δ&lt;i>tolC&lt;/i>, D22, Δ&lt;i>acrB&lt;/i> and BL21(DE3)omp8. A comparison of the activity results of the &lt;i>E. coli&lt;/i> mutants with respect to the known rules related to enhanced activity against Gram-negative bacteria revealed that applicability of the rules i</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-05-29T21:23:42.124Z</modification><creation>2025-05-29T21:23:42.124Z</creation></dates><accession>S-EPMC8128065</accession><cross_references><pubmed>34046630</pubmed><doi>10.1039/d0md00409j</doi></cross_references></HashMap>